Related Experiment Video
Updated: Jul 3, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Advances in asthma and allergy genetics in 2007
1Functional Genomics Laboratory, Arizona Respiratory Center, and the Department of Cell Biology, University of Arizona, Tucson, Ariz, USA. donata@arc.arizona.edu
The Journal of Allergy and Clinical Immunology
|July 16, 2008
Summary
Advances in asthma and allergy genetics reveal complex gene-environment interactions influencing susceptibility. Research highlights T(H)2 immunity gene variants and filaggrin mutations in allergic diseases.
Area of Science:
- Immunology
- Genetics
- Environmental Health
Background:
- Asthma and allergy are complex diseases influenced by multiple factors.
- Understanding genetic contributions is crucial for developing effective treatments.
- Previous research has identified several candidate genes associated with these conditions.
Purpose of the Study:
- To review significant advances in asthma and allergy genetics published in 2007.
- To summarize findings on gene-environment interactions, T(H)2 immunity, and filaggrin mutations.
- To identify novel and confirm known candidate genes related to allergic diseases.
Main Methods:
- Review of association studies published in the Journal in 2007.
- Analysis of research focusing on environmental factors and gene-environment interactions.
- Examination of studies investigating T(H)2 immunity gene variants.
- Evaluation of research on filaggrin mutations and related phenotypes.
Main Results:
- Association studies explored environmental effects and gene-environment interactions on asthma/allergy susceptibility.
- The contribution of T(H)2 immunity gene variants to allergic inflammation was investigated.
- The role of filaggrin mutations in atopic dermatitis and associated phenotypes was examined.
- Novel candidate genes were identified, and the significance of known genes was confirmed.
Conclusions:
- Asthma and allergy are complex diseases resulting from intricate interactions between genetic and environmental factors.
- These interactions modify disease susceptibility by altering organ function during critical developmental periods.
- The reviewed studies underscore the multifactorial nature of allergic diseases and asthma.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...